Visit MSF projects around the world and see what we really do. This month, we are getting a clearer picture of the AIDS epidemic in Malawi and we visit our team in Jordan who are rebuilding shattered lives in the Middle East.
MSF is providing psychological and medical support to scores of women, men and children affected by conflict in the Tana Delta region.
PRESS RELEASE: Following fighting and bombardments in the north of Mali, MSF calls on all parties to the conflict to respect the safety of civilians and to leave health structures untouched.
In the north of Syria’s Idlib province, civilians are being made victims of a terror strategy carried out through intense and indiscriminate bombing, says MSF.
Interview: One year after the start of the political crisis in Mali, insecurity resulting from the military coup, the Tuareg rebellion and the presence of armed Islamist groups in the north have displaced hundreds of thousands of people.
Three years after the 2010 earthquake, the Haitian health care system is still devastated. MSF continues to manage four hospitals built to replace the temporary structures that it set up immediately after January 12, 2010.
Interview: Fabrice Weissman, MSF’s operations advisor, has recently returned from a mission in Syria. Fabrice disccusses the great breadth of the needs in Syria and the lack of international response.
More than 170,000 people are already living in refugee camps in South Sudan. Now the rainy season subsides, people are starting to cross the border again. We tell their stories.
It is with great sadness that MSF marks one year since our two colleagues, Philippe Havet and Andrias Karel Keiluhu (“Kace”), were brutally murdered in Mogadishu.
MSF has resumed medical activities at its maternity hospital in Khost Province, Afghanistan, which were suspended following an explosion in the hospital in April, 2012.
PRESS RELEASE: MSF welcomes the USFDA's approval of bedaquiline, the first new drug active against tuberculosis in 50 years. MSF calls for rapid registration in countries with high drug-resistant tuberculosis burdens.